Efficacy evaluation of a bivalent subunit vaccine against epidemic PEDV heterologous strains with low cross-protection
Journal of Virology · 22.10.2024 · 98 (10)
DOI: 10.1128/jvi.01309-24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Virology, erschienen am 22.10.2024. Verfasst von Xu Song und 17 weiteren Autor:innen. Beteiligte Einrichtung: School of Veterinary Medicine, Hebei Agricultural University, Baoding, China. Hauptthemen laut MEDLINE: Porcine epidemic diarrhea virus, Cross Protection, Swine Diseases, Antibodies, Viral. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: MOST | National Key Research and Development Program of China (NKPs), MOST | National Natural Science Foundation of China (NSFC), JST | Natural Science Foundation of Jiangsu Province (Jiangsu Natural Science Foundation).
Abstract (Originalsprache)
Variant Porcine epidemic diarrhea virus (PEDV), which causes diarrhea and high mortality in piglets, has become a major pathogen, and co-epidemics of different subtypes of the virus have become a very thorny problem for the clinical prevention and control of PEDV. However, cross-protection between epidemic G2a and G2b subtype strains has not been observed, and there is currently no vaccine against both G2a and G2b strains. In this study, we demonstrate the low cross-protection between G2a and G2b strains with piglet immunization and challenge tests. The trimeric full-length S proteins of G2a and G2b variants were purified and a bivalent subunit vaccine against PEDV G2a/G2b-S was developed. In active and passive immune protection tests, the bivalent subunit vaccine produced high neutralizing antibody titers and S-specific immunoglobulin G (IgG) and IgA titers against both the G2a and G2b strains in piglets and sows. In the attack phase of the viruses, the clinical symptoms and microscopic lesions in the immunized groups were significantly alleviated. Importantly, the PEDV G2a/G2b-S bivalent subunit vaccine conferred effective passive immunity against PEDV G2a and G2b challenges in the form of colostrum-derived antibodies from the immunized sows. In conclusion, our data demonstrate the low cross-protection of PEDV epidemic G2a and G2b strains and show that the G2a/G2b-S bivalent subunit vaccine is protective against both G2a and G2b strains. It is therefore a candidate vaccine for PEDV prevention. IMPORTANCE The detection rate of PEDV G2a subtype strains is currently increasing. Although commercial vaccines are available, most vaccines do not exert an ideal protective effect against these strains. Furthermore, there is no definitive research into the cross-protection between G2a and G2b strains, and no bivalent vaccine provides joint protection against both. Therefore, in this study, we investigated the cross-protection between PEDV G2a and G2b strains and designed a candidate bivalent subunit vaccine combining the trimeric S proteins of the G2a and G2b subtypes. We demonstrate that the cross-protection between strains G2a and G2b is poor and that this bivalent subunit vaccine protects piglets from viral attack by inducing both active and passive immunity. This study emphasizes the effectiveness of the PEDV G2a/G2b-S bivalent subunit vaccine and provides a feasible method for the development of efficient PEDV vaccines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Veterinary Medicine, Hebei Agricultural University, Baoding, China.
- Key Laboratory of Veterinary Biological Engineering and Technology, Institute of Veterinary Medicine, Jiangsu Academy of Agricultural Sciences, Nanjing, China.
- Jiangsu Key Laboratory for Food Quality and Safety-State Key Laboratory Cultivation Base of Ministry of Science and Technology, Nanjing, China.
- Jiangsu Coinnovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou University, Yangzhou, China.
- School of Life Sciences, Jiangsu University, Zhenjiang, China.
- GuoTai (Taizhou) Center of Technology Innovation for Veterinary Biologicals, Taizhou, China.
ORCID-Profile: Jizong Li, Baochao Fan, Bin Li
Förderung
- MOST | National Key Research and Development Program of China (NKPs)
- MOST | National Natural Science Foundation of China (NSFC)
- JST | Natural Science Foundation of Jiangsu Province (Jiangsu Natural Science Foundation)
- Jiangsu Agricultural Science and Technology Innovation Fund (JASTIF)
- Innovation Foundation of Jiangsu Academy of Agricultural Sciences
Zitieren
APA
Song, X., Li, Y., Wang, C., Zhao, Y., Yang, S., Guo, R., Hu, M., Sun, M., Zhang, G., Li, Y., Wang, Y., Liu, S., Shen, Y., Li, C., Zhang, X., Li, J., Fan, B., & Li, B. (2024). Efficacy evaluation of a bivalent subunit vaccine against epidemic PEDV heterologous strains with low cross-protection. Journal of Virology, 98(10). https://doi.org/10.1128/jvi.01309-24
Vancouver
Song X, Li Y, Wang C, Zhao Y, Yang S, Guo R, et al. Efficacy evaluation of a bivalent subunit vaccine against epidemic PEDV heterologous strains with low cross-protection. Journal of Virology. 2024;98(10). doi:10.1128/jvi.01309-24
BibTeX
@article{Song2024,
author = {Song, Xu and Li, Yunchuan and Wang, Chuanhong and Zhao, Yongxiang and Yang, Shanshan and Guo, Rongli and Hu, Mi and Sun, Min and Zhang, Gege and Li, Yupeng and Wang, Yi and Liu, Shiyu and Shen, Yaoxin and Li, Chengcheng and Zhang, Xuehan and Li, Jizong and Fan, Baochao and Li, Bin},
title = {Efficacy evaluation of a bivalent subunit vaccine against epidemic PEDV heterologous strains with low cross-protection},
journal = {Journal of Virology},
year = {2024},
volume = {98},
number = {10},
doi = {10.1128/jvi.01309-24}
}
EUVIMED